It
|
En
|
Contacts
|
In evidence
|
n.1 - I nuovi farmaci contro l'epatite C
MENU
The centre
Clinical activities
Pathologies
The foundation
Who we are
The people
Background
In evidence
The technology
Hepatitis A
Hepatitis B
Hepatitis C
Epatite E
Autoimmune Hepatitis (AIH)
Encefalopatia epatica
Primary Biliary Cholangitis (PBC)
Primary Sclerosing Cholangitis (PSC)
Non-Alcholic Steatohepatitis (NASH)
Contacts
The foundation
Research
Education
Support us
The centre
Who we are
The people
Background
In evidence
The technology
Clinical activities
Pathologies
Hepatitis A
Hepatitis B
Hepatitis C
Epatite E
Autoimmune Hepatitis (AIH)
Encefalopatia epatica
Primary Biliary Cholangitis (PBC)
Primary Sclerosing Cholangitis (PSC)
Non-Alcholic Steatohepatitis (NASH)
The foundation
Stephan Krähenbühl
Role
Education
Specialisation/Focus
Visit in
